Start­up mak­ing soft­ware for phar­ma man­u­fac­tur­ing in­dus­try nets $12M+ Se­ries A

Ganymede Bio CEO and co-founder Nathan Clark claims soft­ware for biotechs is 10 to 20 years be­hind oth­er in­dus­tries. His com­pa­ny just re­ceived $12.75 mil­lion to pro­vide drug­mak­ers with more op­tions.

Ganymede Bio is a cloud in­fra­struc­ture provider tar­get­ing the life sci­ence and phar­ma man­u­fac­tur­ing in­dus­tries. The start­up, which was on­ly found­ed this year, un­veiled its Se­ries A round on Tues­day. Com­bined with an ear­li­er seed round, the com­pa­ny has raised a to­tal of $15.6 mil­lion as it works to se­cure more clients in the man­u­fac­tur­ing and bio­phar­ma space.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER